These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2025315)

  • 1. Systemic sclerosis associated with cutaneous exposure to solvent: case report and review of the literature.
    Brasington RD; Thorpe-Swenson AJ
    Arthritis Rheum; 1991 May; 34(5):631-3. PubMed ID: 2025315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized scleroderma after exposure to organic solvents.
    Czirják L; Pócs E; Szegedi G
    Dermatology; 1994; 189(4):399-401. PubMed ID: 7873829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleroderma-like disease following occupational exposure to organic solvents.
    Altomonte A; Zoli A; Galossi A; Mancusa L; Mirone L; Magnavita N; Federico F; Magaro M
    Clin Rheumatol; 1996 Jul; 15(4):416-7. PubMed ID: 8853181
    [No Abstract]   [Full Text] [Related]  

  • 4. [Exposure to solvents in scleroderma: disseminated circumscribed scleroderma (morphea) in a painter exposed to perchloroethylene].
    Hinnen U; Schmid-Grendelmeier P; Müller E; Elsner P
    Schweiz Med Wochenschr; 1995 Dec; 125(50):2433-7. PubMed ID: 8553031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative nailfold capillary microscopy in cutaneous and systemic lupus erythematosus and localized and systemic scleroderma.
    Studer A; Hunziker T; Lütolf O; Schmidli J; Chen D; Mahler F
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):941-5. PubMed ID: 1869681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Bellando-Randone S; Lepri G; Bruni C; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2013 Aug; 72(8):1425-7. PubMed ID: 23572336
    [No Abstract]   [Full Text] [Related]  

  • 7. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
    Maricq HR
    Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registry.
    Muntyanu A; Milan R; Rahme E; Baron M; Netchiporouk E;
    J Am Acad Dermatol; 2024 Mar; 90(3):605-607. PubMed ID: 37182702
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
    Doyle JA; Connolly SM; Winkelmann RK
    Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Symptomatic scleroderma caused by bleomycin].
    Bork K; Korting GW
    Hautarzt; 1983 Jan; 34(1):10-2. PubMed ID: 6188716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin sclerosis as a manifestation of POEMS syndrome.
    Hasegawa M; Orito H; Yamamoto K; Matsushita T; Hamaguchi Y; Fujimoto M; Takehara K
    J Dermatol; 2012 Nov; 39(11):922-6. PubMed ID: 22724593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical generalized morphea-like scleroderma occurring in a patient exposed to organic solvents and having chronic hepatitis C virus infection.
    Aounallah A; Lahouel I; Mokni S; Ksiaa M; Hayouni M; Belajouza C; Kotti F; Saidi W; Boussofara L; El Maalel O; Guerfala M; Sriha B; Denguezli M; Ghariani N; Nouira R
    Indian J Dermatol Venereol Leprol; 2018; 84(2):221-224. PubMed ID: 29451196
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalized morphea-like systemic sclerosis : a subtype of diffuse cutaneous systemic sclerosis presenting with unusual cutaneous features.
    Nagai Y; Igarashi N; Ishikawa O
    Eur J Dermatol; 2008; 18(6):715-6. PubMed ID: 19049937
    [No Abstract]   [Full Text] [Related]  

  • 14. Case of morphea with symmetrical distribution of sclerotic lesions on bilateral forearms accompanied by extensive nail fold capillary abnormalities in multiple fingers.
    Irimada M; Ozawa M; Yamasaki K; Aiba S
    J Dermatol; 2020 Feb; 47(2):e61-e62. PubMed ID: 31762084
    [No Abstract]   [Full Text] [Related]  

  • 15. [Systemic sclerosis (scleroderma) without scleroderma].
    Nadashkevych ON
    Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic sclerosis and digital gangrene without scleroderma.
    Barr WG; Robinson JA
    J Rheumatol; 1988; 15(5):875-7. PubMed ID: 3172105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumoconiosis and systemic sclerosis following 10 years of exposure to polyvinyl chloride dust.
    Studnicka MJ; Menzinger G; Drlicek M; Maruna H; Neumann MG
    Thorax; 1995 May; 50(5):583-5; discussion 589. PubMed ID: 7597677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P2 polymorphisms and susceptibility to scleroderma following exposure to organic solvents.
    Povey A; Guppy MJ; Wood M; Knight C; Black CM; Silman AJ
    Arthritis Rheum; 2001 Mar; 44(3):662-5. PubMed ID: 11263781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do solvents cause scleroderma?
    Walder BK
    Int J Dermatol; 1983 Apr; 22(3):157-8. PubMed ID: 6853006
    [No Abstract]   [Full Text] [Related]  

  • 20. Solvent dermatitis.
    Andersen KE
    Prog Clin Biol Res; 1986; 220():133-8. PubMed ID: 2948192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.